BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34284482)

  • 1. 68Ga-PSMA Uptake Patterns of Clear Cell Renal Carcinoma Across Different Histopathological Subtypes.
    Oflas M; Ozluk Y; Sanli O; Ozkan ZG; Kuyumcu S
    Clin Nucl Med; 2022 Jan; 47(1):e45-e46. PubMed ID: 34284482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidental Intrahepatic Hepatocellular Cholangiocarcinoma Detected on 68Ga-PSMA PET/CT.
    Kang C; Jiang JY; Lee ME; Shen L; Mansberg R
    Clin Nucl Med; 2022 Mar; 47(3):e291-e293. PubMed ID: 35020661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.
    Has Simsek D; Civan C; Erdem S; Sanli Y
    Clin Nucl Med; 2021 Jul; 46(7):579-581. PubMed ID: 33782292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid Incidentaloma on 68Ga-PSMA-11 PET/CT Leading to Detection of Thyroid Metastasis in Metastatic Prostate Carcinoma.
    Parghane RV; Basu S
    Clin Nucl Med; 2022 Mar; 47(3):e300-e301. PubMed ID: 34690291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
    Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
    J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 68Ga-PSMA Uptake in Brain Metastasis of Gastric Carcinoma.
    Kesim S; Oksuzoglu K
    Clin Nucl Med; 2022 Sep; 47(9):e585-e586. PubMed ID: 35930713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CT.
    Weitzer F; Nazerani-Hooshmand T; Aigner RM; Pernthaler B
    Clin Nucl Med; 2021 Jul; 46(7):e358-e359. PubMed ID: 34081054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive evaluation of
    Gao J; Xu Q; Fu Y; He K; Zhang C; Zhang Q; Shi J; Zhao X; Wang F; Guo H
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):561-569. PubMed ID: 32623502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT With 68Ga-PSMA and 18F-FDG in Metastatic Adenoid Cystic Carcinoma: Report of 2 Cases.
    Isgoren S; Hekimsoy T; Koroglu E; Demir H
    Clin Nucl Med; 2022 May; 47(5):e423-e424. PubMed ID: 35234196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing Meningioma From Metastasis of Prostate Cancer on 68Ga-PSMA PET/CT.
    Filizoglu N; Oksuzoglu K; Ozguven S
    Clin Nucl Med; 2021 Nov; 46(11):e553-e555. PubMed ID: 34606488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis.
    Hu X; Wu Y; Yang P; Wang J; Wang P; Cai J
    Int Braz J Urol; 2022; 48(6):891-902. PubMed ID: 34003611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga-PSMA PET/CT Scan on Postoperative Assessment of Sinonasal Glomangiopericytoma.
    Sakthivel P; Kumar A; Arunraj ST; Singh CA; Kumar R
    Clin Nucl Med; 2021 Sep; 46(9):e478-e479. PubMed ID: 33826565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management.
    Pathmanathan S; Tariq A; Pearce A; Rhee H; Kyle S; Raveenthiran S; Wong D; McBean R; Marsh P; Goodman S; Dhiantravan N; Esler R; Dunglison N; Navaratnam A; Yaxley J; Thomas P; Pattison DA; Goh JC; Gan CL; Roberts MJ
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):295-303. PubMed ID: 37592084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental Detection of Thyroid Metastases From Renal Cell Carcinoma Using 68Ga-PSMA PET/CT to Assess Prostate Cancer Recurrence.
    Zacho HD; Nielsen JB; Dettmann K; Haberkorn U; Petersen LJ
    Clin Nucl Med; 2017 Mar; 42(3):221-222. PubMed ID: 28033223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary lymph-node staging with
    Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
    Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De Quervain Subacute Thyroiditis With Moderate PSMA Uptake Mimicking Thyroid Metastasis of Renal Cell Carcinoma.
    Leder T; Drescher R; Gühne F; Theis B; Freesmeyer M
    Clin Nucl Med; 2022 Mar; 47(3):221-222. PubMed ID: 34690294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT.
    Rosar F; Bartholomä M; Maus S; Privé BM; Khreish F; Franssen GM; Derks YHW; Nagarajah J; Ezziddin S
    Clin Nucl Med; 2022 May; 47(5):435-436. PubMed ID: 35234197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare Case of Small Cell Metastatic Prostatic Adenocarcinoma, Properly Staged by 68Ga-PSMA PET/CT Scan.
    Golestani ZB; Soltani S; Kalantari MR; Ghorbani HR; Aghaee A
    Clin Nucl Med; 2022 Mar; 47(3):e259-e261. PubMed ID: 35025791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Lung Findings Detected by 68Ga-PSMA PET/CT for Staging Purposes in Patients With Prostate Cancer.
    Karasah Erkek B; Ömür Ö; Özkök S; Turna B
    Clin Nucl Med; 2022 Jan; 47(1):e17-e19. PubMed ID: 34028424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of
    Siva S; Callahan J; Pryor D; Martin J; Lawrentschuk N; Hofman MS
    J Med Imaging Radiat Oncol; 2017 Jun; 61(3):372-378. PubMed ID: 28116853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.